In lung cancer cells, HMGB1 levels were increased with combined ATR inhibition and ablative radiotherapy compared to radiotherapy alone (Fig. 5A), suggesting a potential synergistic effect between ATR inhibition and radiotherapy in boosting HMGB1-mediated immunogenicity. The gene discussed is ATR; the disease is lung cancer.